Companies have been battling with a lack of private investment in recent years but could now face a lack of government funds.

The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...

We hoped industry layoffs would relent in 2024. That's not what happened. Overall, biopharma layoffs rose 3% last year compared to 2023, according to an analysis of yearly data. So, here we are ...

Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the appointment of Robert Panting, Ph.D., to the newly ...

The Brevard-based doctor and former congressman said: "The concern of many people is that big Pharma was behind this, which ...

New Jersey's powerful pharmaceutical industry, already under pressure to rein in prices, is facing new headwinds from a Trump ...

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

Xeris Biopharma (XERS) shares ended the last trading session 5.6% higher at $5.51. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

Powered by Real-World Expertise: Cliniphai has built deep operational experience across clinical studies and is working with trusted partners that have spent decades ensuring linguistic accuracy in ...